Author: OurCrowd

[BrightInsight in GlobeNewswire] BrightInsight recognized among Newsweek’s World’s Best Digital Health Companies 2024 list

SAN JOSE, Calif., April 24, 2024 (GLOBE NEWSWIRE) — BrightInsight, Inc., the trusted partner and de-facto platform driving value for top biopharma compliant digital health solutions, is thrilled to announce it has been named to Newsweek’s list of The World’s Best Digital Health Companies 2024. This recognition comes on the heels of BrightInsight being named to Forbes 2024 List of America’s Best Startup Employers earlier this month. Read...

Read More

[Biolojic in GlobeNewswire] Biolojic Design announces that Nektar Therapeutics has exercised its license option to develop an AI-designed agonistic antibody targeting TNFR2 for the treatment of autoimmune diseases

TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021. Read...

Read More